Startup profile · funding coverage
Nourish funding, valuation and investors
Virtual dietitian-led metabolic health clinic — licensed clinicians, not wellness content.
Keep track of Nourish
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series C
$100M · May 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$100M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · New York, New York
Overview
Nourish operates what it describes as the country's largest dietitian-led metabolic health clinic, delivering virtual nutrition care with licensed professionals for conditions including diabetes and GLP-1 coordination. The New York company raised $100M Series C in May 2026, bringing total funding to $215M per VC News Daily. Investors want care models employers and payers can credential with documented clinical outcomes.
Why Nourish is interesting
Nourish's $100M Series C ($215M total) validates payer-credible clinical models in metabolic health as GLP-1 and employer wellness budgets converge — clinicians show up, not chatbots.
Product & use cases
Virtual metabolic health clinic staffed by licensed dietitians — telehealth nutrition care with outcomes tracking for chronic conditions.
- Diabetes and metabolic condition nutrition management
- GLP-1 patient nutrition coordination
- Employer and payer-contracted virtual dietitian care
Key facts
- Series C (May 2026): $100M; $215M total funding (VC News Daily)
- Largest dietitian-led metabolic health clinic positioning
- NYC virtual clinical care model
- GLP-1 and chronic condition nutrition focus
Funding history (newest first)
Series C
2026-05 $100MSource: https://vcnewsdaily.com/
Competitive landscape
Edge: Licensed-clinician-led model with scale — credentialing-friendly for payers vs. generic wellness apps.
Metabolic health is crowded post-GLP-1 boom. Nourish wins on dietitian credentialing and outcomes data for payer contracts; reimbursement and clinical validation are gating factors.
-
Omada Health direct
Chronic condition digital care; overlapping employer channel.
-
Noom adjacent
Weight/metabolic consumer app; less clinician-led.
-
Teladoc adjacent
Virtual care incumbent; broader telehealth scope.
Notable stories
- $100M Series C rewards licensed-clinician models over wellness wrappers.
- Metabolic health converges GLP-1 coordination, diabetes prevention, employer spend.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Nourish's financing or category context.
FAQs about Nourish
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.